Conferences Ionis Pharmaceuticals is attending in 2026–2027

ionis.com

Ionis Pharmaceuticals is listed at 2 conferences on Tnuki's calendar in 2026–2027: TIDES Europe 2026 (on the program) and TIDES USA 2027 (Bronze Sponsor). Ionis Pharmaceuticals develops RNA-targeted medicines, including antisense oligonucleotide therapeutics, for genetic and other diseases. As of Sep 29, 2026.

ConferenceDetailsInvolvementTnuki guide
TIDES Europe 2026: Oligonucleotide & Peptide TherapeuticsOligonucleotide & peptide drug developersOfficial site
Amsterdam, Netherlands ~900 attendees On the programNo booth or sponsorship in the organizer’s published lists
Program 2 talks
Attending
  • Executive Director, CMC Regulatory Affairs
  • Senior Research Associate, Manufacturing & Operatiions
Attendee mix: Mostly industry; oligonucleotide and peptide R&D scientists, CMC and manufacturing specialists, regulatory and BD
Open the guide Search and filter attendees
TIDES USA 2027: Oligonucleotide & Peptide TherapeuticsOligonucleotide & peptide drug developersOfficial site
Boston, MA ~2k attendees ◇Bronze SponsorAs published by Informa ConnectTalks and attendees: not yet availableAttendee mix: Mostly industry; oligonucleotide and peptide R&D scientists, CMC and manufacturing specialists, regulatory and BD Guide coming soon

We hold published exhibitor, sponsor, program or attendee lists for 29 of the 90 conferences on our calendar, so this page shows Ionis Pharmaceuticals’s involvement at those 29 only — it is not a complete record of where they go. Organizers typically publish a list around six months before the event, so coverage grows over time.

Instantly find decision makers at Ionis Pharmaceuticals

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

See what Tnuki can do

Explore our deep integration of account and market intelligence, in one easy-to-use chat.

Or talk to a human →